Clinical Trials Browser

Phase 1/2 × Interventional × trebananib × Clear all

NCT01290263 2017-07-02

Amgen 386 for Recurrent Glioblastoma

Phase 1/2 Completed

48 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Glioma

NCT01666977 2016-06-03

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung